Neelam Mukherjee - Concepedia

Author

Neelam Mukherjee

The University of Texas Health Science Center at San Antonio ORCID

Also Known As

N Mukherjee, Nayanika Mukherjee, Neelam Mukherjee, Neelam Z. Mukherjee

Publications

649

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio The University of Texas MD Anderson Cancer Center The University of Texas at San Antonio Urology San Antonio Mays Cancer Center at UT Health San Antonio

About

Neelam Mukherjee is an author at The University of Texas Health Science Center at San Antonio specializing in cancer research, radiation oncology, and dna methylation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	39
2	Cancer Genetics	1	1	39
3	Epigenetics	1	1	39
4	Cancer Research	1	1	39
5	Dna Methylation	1	1	39

Neelam Mukherjee

Publications

342

Citations

H-Index

Page 1

	Year	Citations
Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer Neelam Mukherjee, Niannian Ji, Vincent Hurez, Oncotarget	2018	63
Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial Dharam Kaushik, Pankil Shah, Neelam Mukherjee, Prostate Cancer and Prostatic Diseases	2021	59
DNA Methylation and Flavonoids in Genitourinary Cancers Neelam Mukherjee, Addanki P. Kumar, Rita Ghosh Current Pharmacology Reports Oncogenic AgentMedicineDna MethylationCancer GenomicsCancer Genetics	2015	39
SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer Neelam Mukherjee, Eduardo Cárdenas, Roble Bedolla, Oncotarget	2017	36
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial Niannian Ji, Neelam Mukherjee, Edwin E. Morales, OncoImmunology	2019	36
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer Robert S. Svatek, Niannian Ji, Essel De Leon, Cancer Immunology Research	2018	29
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study Niannian Ji, Neelam Mukherjee, Ryan M. Reyes, Journal for ImmunoTherapy of Cancer	2021	28
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation Ryan M. Reyes, Yilun Deng, Deyi Zhang, Journal for ImmunoTherapy of Cancer	2021	22
γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer Niannian Ji, Neelam Mukherjee, Zhen‐Ju Shu, Cancer Immunology Research	2021	18
<scp>KLRF1</scp>, a novel marker of <scp>CD56<sup>bright</sup> NK</scp> cells, predicts improved survival for patients with locally advanced bladder cancer Neelam Mukherjee, Niannian Ji, Xi Tan, Cancer Medicine	2022	12

Page 1